Evidence map›Paper›PMID 36288039›Full record

ReviewTropical medicine and infectious disease2022

COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-Analysis.

Shaimaa Abdelaziz Abdelmoneim, Malik Sallam, Dina Mohamed Hafez, Ehab Elrewany, Hesham Metwalli Mousli, Elsayed Mohamed Hammad, Sally Waheed Elkhadry, Mohammed Fathelrahman Adam, Amr Abdelraouf Ghobashy, Manal Naguib and 3 more

Abstract readReview
In one paragraph

Review in Tropical medicine and infectious disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Evidence brief on facilitators, barriers and hesitancy of COVID-19 booster doses in Canada.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Vaccination Open Day: A Cross-Sectional Study on the 2023 Experience in Lombardy Region, Italy.International journal of environmental research and public health · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shaimaa Abdelaziz AbdelmoneimClinical Research Administration, Alexandria Directorate of Health Affairs, Egyptian Ministry of Health and Population, Alexandria 21554, Egypt.ORCID 0000-0002-9197-6396
Malik SallamDepartment of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan.ORCID 0000-0002-0165-9670
Dina Mohamed HafezPharmacy Department, Alexandria University Students Hospital, Alexandria 5422023, Egypt.ORCID 0000-0001-7244-0118
Ehab ElrewanyTropical Health Department, High Institute of Public Health, Alexandria University, Alexandria 21561, Egypt.
Hesham Metwalli MousliContinuous Quality Improvement & Patient Safety Department, Alexandria Urology Hospital, Alexandria 5442045, Egypt.ORCID 0000-0001-7757-4975
Elsayed Mohamed HammadFaculty of Medicine, Alexandria University, Alexandria 21544, Egypt.ORCID 0000-0002-7523-2346
Sally Waheed ElkhadryDepartment of Epidemiology and Preventive Medicine, National Liver Institute, Menoufia University, Menoufia 32511, Egypt.ORCID 0000-0001-9305-3045
Mohammed Fathelrahman AdamFaculty of Pharmacy, University of Science and Technology, Khartoum 12810, Sudan.ORCID 0000-0001-6930-9004
Amr Abdelraouf GhobashyFaculty of Medicine, Kafrelsheikh University Hospital, Kafr el-Sheikh 33516, Egypt.
Manal NaguibEgyptian Ministry of Health and Population, Alexandria 21554, Egypt.ORCID 0000-0001-5909-4759
Ahmed El-Sayed Nour El-DeenDepartment of Physiology, Faculty of Medicine, Al-Azhar University, Assiut 71524, Egypt.ORCID 0000-0002-8377-6255
Narjiss AjiFaculty of Medicine and Pharmacy of Rabat, Mohammed V University, Rabat 10100, Morocco.ORCID 0000-0001-6606-8727
Ramy Mohamed GhazyTropical Health Department, High Institute of Public Health, Alexandria University, Alexandria 21561, Egypt.ORCID 0000-0001-7611-706X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The World Health Organization (WHO) recommended coronavirus disease 2019 (COVID-19) booster dose vaccination after completing the primary vaccination series for individuals ≥18 years and most-at-risk populations. This study aimed to estimate the pooled proportion of COVID-19 vaccine booster dose uptake and intention to get the booster dose among general populations and healthcare workers (HCWs). We searched PsycINFO, Scopus, EBSCO, MEDLINE Central/PubMed, ProQuest, SciELO, SAGE, Web of Science, Google Scholar, and ScienceDirect according to PRISMA guidelines. From a total of 1079 screened records, 50 studies were extracted. Meta-analysis was conducted using 48 high-quality studies according to the Newcastle-Ottawa Scale quality assessment tool. Using the 48 included studies, the pooled proportion of COVID-19 vaccine booster dose acceptance among 198,831 subjects was 81% (95% confidence interval (CI): 75-85%,

Indexed as

communicable disease controlpublic health practicesecondary immunizationvaccine attitudevaccine hesitancyvaccine preferencevaccine rejectionvaccine resistance

Identifiers

PMID36288039
PMCPMC9611447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.